Advanced Registry Search Results
Search Criteria
Search for vertex pharmaceuticals in registrations and Lobbying Activity Reports
Refine By
Document Type
Registrations Status
Activity Type
Subject Matter of the Lobbying Activity
Ministries/Provincial Entities
If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search
Advanced Registry Search Results
Results: 1-30 of 30
-
Vertex Pharmaceuticals (Canada) Incorporated
-
Vertex Pharmaceuticals (Canada) Incorporated
-
Vertex Pharmaceuticals (Canada) Inc.
Activity type: Consultant Lobbyist
Lobbyist: Jason Craik, Composite Public Affairs Inc.
Registration: 1 of 1 (2019-01-01 to2019-03-14 )
Posted: 2019-01-11Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
Vertex Pharmaceuticals (Canada) Inc.
Activity type: Consultant Lobbyist
Lobbyist: Will McMartin, Composite Public Affairs Inc.
Registration: 1 of 2 (2019-01-01 to2020-05-04 )
Posted: 2019-01-11Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
Vertex Pharmaceuticals (Canada) Inc.
Activity type: Organization
Senior Officer: Monty Keast
Registration: 4 of 4 (2017-08-24 to2018-02-24 )
Posted: 2017-08-24Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
Vertex Pharmaceuticals (Canada) Inc.
Activity type: Organization
Senior Officer: Martin Weiss
Registration: 3 of 4 (2017-01-30 to2017-07-29 )
Posted: 2017-01-30Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
Vertex Pharmaceuticals (Canada) Inc.
Activity type: Organization
Senior Officer: Martin Weiss
Registration: 2 of 4 (2016-08-02 to2017-01-29 )
Posted: 2016-08-02Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
Vertex Pharmaceuticals (Canada) Inc
Activity type: Consultant Lobbyist
Lobbyist: Dennis Chan, Pathway Advisory Services
Registration: 2 of 10 (2016-02-15 to2020-05-04 )
Posted: 2016-02-25Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
Vertex Pharmaceuticals (Canada) Inc.
Activity type: Organization
Senior Officer: Martin Weiss
Registration: 1 of 4 (2016-02-02 to2016-07-31 )
Posted: 2016-02-04Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
Vertex Pharmaceuticals (Canada) Inc
Activity type: Consultant Lobbyist
Lobbyist: Dennis Chan
Registration: 1 of 10 (2015-01-05 to2015-02-27 )
Posted: 2015-01-15Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
Vertex Pharmaceuticals (Canada) Inc.
Activity type: Consultant Lobbyist
Lobbyist: Michael Harrison, GCI Canada Group
Registration: 2 of 2 (2012-03-19 to2012-12-31 )
Posted: 2012-03-19Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
Vertex Pharmaceuticals (Canada) Inc.
Activity type: Consultant Lobbyist
Lobbyist: Michael Harrison, GCI Group
Registration: 1 of 2 (2011-11-28 to2011-12-30 )
Posted: 2011-11-29Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
Vertex Pharmaceuticals (Canada) Inc
-
Vertex Pharmaceuticals (Canada) Inc
-
Vertex Pharmaceuticals (Canada) Inc
-
Vertex Pharmaceuticals (Canada) Inc
-
Vertex Pharmaceuticals (Canada) Inc
-
Vertex Pharmaceuticals (Canada) Inc
-
Vertex Pharmaceuticals (Canada) Inc
-
Vertex Pharmaceuticals (Canada) Inc
-
Vertex Pharmaceuticals (Canada) Inc
-
Vertex Pharmaceuticals (Canada) Inc.
-
Vertex Pharmaceuticals
Activity type: Consultant Lobbyist
Lobbyist: Sophia Cote, FleishmanHillard High Road Corp.
Registration: 1 of 1 (2018-11-05 to2019-06-26 )
Posted: 2018-11-06Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
Vertex Pharmaceuticals
Activity type: Consultant Lobbyist
Lobbyist: Elyse Mitchell, FleishmanHillard HighRoad Corp.
Registration: 1 of 1 (2018-10-25 to2018-12-31 )
Posted: 2018-11-06Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
Vertex Pharmaceuticals
Activity type: Consultant Lobbyist
Lobbyist: Kyle Marsh, FleishmanHillard HighRoad
Registration: 1 of 1 (2018-02-20 to2018-11-08 )
Posted: 2018-02-21Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
Vertex Pharmaceuticals Inc.
Activity type: Consultant Lobbyist
Lobbyist: Gabriel Garfinkel, Garfinkel and Partners Strategies
Registration: 1 of 1 (2016-01-01 to2016-11-23 )
Posted: 2016-01-11Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
Vertex Pharmaceuticals (Canada) Inc.
Activity type: Consultant Lobbyist
Lobbyist: Michael McCarthy, Grosso McCarthy Inc.
Registration: 1 of 1 (2013-07-16 to2013-11-28 )
Posted: 2013-07-15Submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. -
Vertex Pharmaceuticals (Canada) Incorporated
Activity type: Consultant Lobbyist
Lobbyist: Beatriz Grigsby-Larson, Global Public Affairs Inc.Activity date:2024-01-23
Posted:2024-02-15
Activity number:5189-32444 Senior public office holders:- Ian Rongve, ADM, Strategic Innovation | Health
Subject matters: 1 -
Vertex Pharmaceuticals (Canada) Incorporated
Activity type: Consultant Lobbyist
Lobbyist: Beatriz Grigsby-Larson, Global Public Affairs Inc.Activity date:2023-08-30
Posted:2023-09-15
Activity number:5189-28450 Senior public office holders:- Maija Duffy, Executive Director, Life Sciences, PharmaCare Benefits Branch | Jobs, Economic Development and Innovation
- Tijana Fazlagic, Executive Director, Innovation | Health
- Kevin Samra, Executive Director | Health
Subject matters: 1 -
Vertex Pharmaceuticals (Canada) Incorporated
Activity type: Consultant Lobbyist
Lobbyist: Beatriz Grigsby-Larson, Global Public Affairs Inc.Activity date:2023-08-22
Posted:2023-09-15
Activity number:5189-28847 Senior public office holders:- Terry Harrison, Chief of Staff | Jobs, Economic Development and Innovation
Subject matters: 1
- Date Modified: